{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:00:09Z","timestamp":1784973609500,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd009230","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,8,3]],"date-time":"2014-08-03T00:00:00Z","timestamp":1407024000000}}],"reference-count":65,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009230.pub2","type":"journal-article","created":{"date-parts":[[2014,8,3]],"date-time":"2014-08-03T16:10:45Z","timestamp":1407082245000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia"],"prefix":"10.1002","volume":"2014","author":[{"given":"Magdolna","family":"Tardy","sequence":"first","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; M\u00f6hlstr. 26 M\u00fcnchen Germany 81675"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Huhn","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinikum der Technischen Universit\u00e4t M\u00fcnchen; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; Klinikum rechts der Isar M\u00fcnchen Bavaria Germany 81675"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf R","family":"Engel","sequence":"additional","affiliation":[{"name":"Ludwig-Maximilians-University Munich; Psychiatric Hospital; Nussbaumstr. 7 Muenchen Germany 80336"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen; Department of Psychiatry and Psychotherapy; Ismaningerstrasse 22 M\u00fcnchen Germany 81675"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,8,3]]},"reference":[{"key":"10.1002\/14651858.CD009230.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1176\/ajp.120.10.1010","article-title":"Comparison of four regimens in newly admitted female schizophrenics","volume":"120","author":"Childers","year":"1964","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD009230.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/archpsyc.1971.01750170020004","article-title":"Drug treatment in newly admitted schizophrenic patients","volume":"25","author":"Clark","year":"1971","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD009230.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archpsyc.1964.01720210028005","article-title":"Phenothiazine treatment in acute schizophrenia","volume":"10","author":"National Institute of Mental Health Psychopharmacology Research Branch Collaborative Study Group","year":"1964","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005053-196808000-00009","article-title":"Predicting response to phenothiazines: the right drug for the right patient","volume":"147","author":"Galbrecht","year":"1968","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"2","key":"10.1002\/14651858.CD009230.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00403632","article-title":"The comparative effectiveness of eight phenothiazines","volume":"7","author":"Hanlon","year":"1965","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD009230.pub2-BIB0006|cit6","first-page":"698","article-title":"Drug treatment of schizophrenic patients. A comparative evaluation of chlorpromazine, chloprothixene, fluphenazine, reserpine, thioridazine and triflupromazine","volume":"23","author":"Lasky","year":"1962","journal-title":"Diseases of the Nervous System"},{"issue":"6","key":"10.1002\/14651858.CD009230.pub2-BIB0007|cit7","first-page":"369","article-title":"Differences in clinical effects of three phenothiazines in \"acute\" schizophrenia","volume":"28","author":"National Institute of Mental Health Psychopharmacology Research Branch Collaborative Study Group","year":"1967","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0447.1974.tb08044.x","article-title":"A controlled study of the antipsychotic and sedative effects of neuroleptic drugs and amphetamine in chronic schizophrenics. A clinical and experimental-psychological study","volume":"249","author":"Cesarec","year":"1974","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"1","key":"10.1002\/14651858.CD009230.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0447.1973.tb04399.x","article-title":"Clinical and work performance variables in phenothiazine therapy of schizophrenia","volume":"49","author":"Chacon","year":"1973","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"9","key":"10.1002\/14651858.CD009230.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/070674378803300906","article-title":"Relationship of adverse drug reactions to length of hospital-stay in genetically subgrouped schizophrenics","volume":"33","author":"Galdi","year":"1988","journal-title":"Canadian Journal of Psychiatry [Revue Canadienne de Psychiatrie]"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-0447.1968.tb01994.x","article-title":"Fluphenazine in the long term treatment of psychoses. A preliminary communication","volume":"203","author":"Gunby","year":"1968","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1192\/bjp.110.467.531","article-title":"Thioproperazine in chronic schizophrenia","volume":"110","author":"Hordern","year":"1964","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD009230.pub2-BIB0016|cit13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/schbul\/9.4.528","article-title":"Low dose medication strategies in the maintenance treatment of schizophrenia","volume":"9","author":"Kane","year":"1983","journal-title":"Schizophrenia Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD009230.pub2-BIB0015|cit14","first-page":"20","article-title":"Low-dose neuroleptics in outpatient schizophrenics","volume":"18","author":"Kane","year":"1982","journal-title":"Psychopharmacology Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD009230.pub2-BIB0013|cit15","first-page":"533","article-title":"High-dose versus low-dose strategies in the treatment of schizophrenia","volume":"21","author":"Kane","year":"1985","journal-title":"Psychopharmacology Bulletin"},{"issue":"8","key":"10.1002\/14651858.CD009230.pub2-BIB0014|cit16","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archpsyc.1983.01790070083010","article-title":"Low-dose neuroleptic treatment of outpatient schizophrenics. I. Preliminary results for relapse rates","volume":"40","author":"Kane","year":"1983","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","article-title":"Antipsychotic drug equivalents and dose-years: a standardized method for comparing exposure to different drugs","volume":"67","author":"Andreasen","year":"2010","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0019|cit19","volume-title":"Psychische Erkrankungen. Klinik und Therapie","author":"Berger","year":"2003"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD009230.pub2-BIB0021|cit21","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/135581960000500105","article-title":"Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action)","volume":"5","author":"Campbell","year":"2000","journal-title":"Journal of Health Services Research and Policy"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM199403103301006","article-title":"Schizophrenia","volume":"330","author":"Carpenter","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0024|cit24","doi-asserted-by":"crossref","unstructured":"David A Adams Clive E Eisenbruch M Quraishi Seema N Rathbone J Depot fluphenazine decanoate and enanthate for schizophrenia Cochrane Database of Systematic Reviews 2004 10.1002\/14651858.CD000307","DOI":"10.1002\/14651858.CD000307"},{"issue":"12","key":"10.1002\/14651858.CD009230.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1176\/ajp.132.12.1237","article-title":"Overview: maintenance therapy in psychiatry: I. Schizophrenia","volume":"132","author":"Davis","year":"1975","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0026|cit26","article-title":"Antipsychotic drugs","volume-title":"Comprehensive Textbook of Psychiatry","author":"Davis","year":"1989"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0027|cit27","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa Cape Town 2000"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"Der-Simonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009230.pub2-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009831","article-title":"Haloperidol versus first generation antipsychotics for schizophrenia","author":"Dold","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"13","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/15622970510030090","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP)-Guidelines for biological treatment of schizophrenia, part 1: Acute treatment of schizophrenia","volume":"6","author":"Falkai","year":"2005","journal-title":"World Journal of Biological Psychiatry"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.schres.2010.10.016","article-title":"Relative indices of treatment effect may be constant across different definitions of response in schizophrenia trials","volume":"126","author":"Furukawa","year":"2011","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0035|cit35","volume-title":"Behandlungsleitlinie Schizophrenie","author":"Gaebel","year":"2006"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0037|cit37","article-title":"Clinical Global Impressions Scale","volume-title":"ECDEU Assessment Manual for Psychopharmacology (DOTES: Dosage Record and Treatment Emergent Symptom Scale)","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0038|cit38","volume-title":"Dosierung der Neuroleptika. Ein Leitfaden f\u00fcr Klinik und Praxis unter besonderer Ber\u00fccksichtigung psychotisch Kranker","author":"Haase","year":"1983"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0039|cit39","doi-asserted-by":"crossref","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics In: Higgins JPT, Green S (editors). Cochrane Handbook forSystematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The CochraneCollaboration, 2008. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184.ch16"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0040|cit40","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia-cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1)","volume":"63","author":"Jones","year":"2006","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD009230.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4088\/JCP.10m06306","article-title":"A randomized placebo-controlled trial of asenapine for the prevention of relapse of schizophrenia after long-term treatment","volume":"72","author":"Kane","year":"2011","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0043|cit43","volume-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0044|cit44","volume-title":"Diagnosis and Drug Treatment of Psychiatric Disorders","author":"Klein","year":"1969"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0045|cit45","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of brief psychiatric rating scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"A meta-analysis comparing second-generation and first-generation antipsychotics for schizophrenia","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"issue":"9657","key":"10.1002\/14651858.CD009230.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0051|cit51","unstructured":"Lohse MJ Lorenzen A M\u00fcller-Oerlinghausen B Psychotropic drugs Arzneimittel Verordnungs Report 2005 820 64"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00127-004-0762-4","article-title":"Schizophrenia and employment-a review","volume":"39","author":"Marwaha","year":"2004","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD009230.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001949.pub3","article-title":"Pimozide for schizophrenia or related psychoses","author":"Mothi","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0056|cit56","doi-asserted-by":"crossref","unstructured":"Nolte S Wong D Latchford G Boyle O Anaenugwu A Amphetamines for schizophrenia Cochrane Database of Systematic Reviews 2004 10.1002\/14651858.CD004964","DOI":"10.1002\/14651858.CD004964"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0058|cit58","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions In: Higgins JPT, Green S (editors). Cochrane Handbook forSystematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The CochraneCollaboration, 2008. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184.ch12"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.1145194","article-title":"Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons","volume":"188","author":"Seeman","year":"1975","journal-title":"Science"},{"issue":"8","key":"10.1002\/14651858.CD009230.pub2-BIB0060|cit60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009227","article-title":"Flupenthixol versus low-potency first generation antipsychotic drugs for schizophrenia","author":"Tardy","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD009230.pub2-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009268","article-title":"Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia","author":"Tardy","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD009230.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009369","article-title":"Perphenazine versus low-potency first generation antipsychotic drugs for schizophrenia","author":"Tardy","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD009230.pub2-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009396","article-title":"Trifluoperazine versus low-potency first generation antipsychotic drugs for schizophrenia","author":"Tardy","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009230.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archpsyc.1978.01770260031002","article-title":"Suicide in schizophrenics, manics, depressives, and surgical controls: a comparison with general population suicide mortality","volume":"35","author":"Tsuang","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD009230.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009230.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T12:23:28Z","timestamp":1709036608000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009230.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,3]]},"references-count":65,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009230.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,3]]}}}